Table 5 Sensitivity analyses with inclusion of colchicine in the main model or with immune disease in the model
From: Allopurinol use and the risk of acute cardiovascular events in patients with gout and diabetes
|  | Main modela + colchicine | Main modela + immune disease | ||
|---|---|---|---|---|
| Â | Incident MI or stroke | |||
| Â | Hazard ratio (95% CI) | p-value | Hazard ratio (95% CI) | p-value |
Allopurinol User | ||||
 Current | 0.68 (0.54, 0.85) | 0.001 | 0.67 (0.53, 0.84) | 0.0006 |
 Previous | Ref |  | Ref |  |
Immune disease | -- | -- | 1.04 (0.78, 1.37) | 0.81 |
Colchicine | 0.80 (0.55, 1.18) | 0.26 | -- | -- |